Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:09 PM
Ignite Modification Date: 2025-12-25 @ 2:09 PM
NCT ID: NCT02043366
Description: None
Frequency Threshold: 0
Time Frame: Incidence of adverse effects was evaluated during 24h after surgery
Study: NCT02043366
Study Brief: Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Normal Saline Normal saline is intravenously administrated before anesthesia induction and intraoperative pain management was with remifentanil Normal Saline None None 0 28 0 28 View
Flurbiprofen AxetilⅠ Flurbiprofen axetil is intravenously administrated at a dose of 1.0mg/ kg before anesthesia induction and intraoperative pain management was with remifentanil Flurbiprofen axetil: Flurbiprofen axetil is intravenously administrated None None 0 28 0 28 View
Flurbiprofen AxetilⅡ Flurbiprofen axetil is intravenously administrated at a dose of 1.0mg/ kg before the skin closure and intraoperative pain management was with remifentanil Flurbiprofen axetil: Flurbiprofen axetil is intravenously administrated None None 0 28 0 28 View
Butorphanol Butorphanol is intravenously administrated at a dose of 20μg/ kg before anesthesia induction and intraoperative pain management was with remifentani None None 0 28 0 28 View
Butorphanol-Flurbiprofen Axetil A dose of 10μg/ kg butorphanol and a dose of 0.5mg/ kg flurbiprofen axetil are intravenously administrated before anesthesia induction and intraoperative pain management was with remifentani None None 0 28 0 28 View
Sufentanil Normal saline is intravenously administrated before anesthesia induction and intraoperative pain management was with sufentanil None None 0 28 0 28 View
Serious Events(If Any):
Other Events(If Any):